Olivier Brandicourt announces Sanofi Committee changes

 

Chief Executive Officer and Executive Committee Chair, Olivier Brandicourt, has announced a number of changes to Sanofi’s Committee in support of the company's recently announced 2020 Strategic Roadmap.


Olivier Charmeil, Executive Vice President and General Manager, General Medicines and Emerging Markets*

 

Jérôme Contamine, Executive Vice President, finance

Peter Guenter, Executive Vice President and General Manager, diabetes & cardiovascular*

Carsten Hellmann, Executive Vice President and General Manager of Merial

Karen Linehan, Executive Vice President, legal affairs and general counsel

David Loew, Executive Vice President and General Manager of Sanofi Pasteur

Philippe Luscan, Executive Vice President, global industrial affairs

Muzammil Mansuri, Ph.D., Executive Vice President, strategy & business development

David Meeker, MD, Executive Vice President and General Manager of Sanofi Genzyme

Ameet Nathwani, MD, Executive Vice President, medical affairs

Roberto Pucci, Executive Vice President, human resources

Elias Zerhouni, MD, President, global research & development.

*Denotes change in position for existing Executive Committee member.

Make a comment

To voice your opinion, please Log in or Register.